183 related articles for article (PubMed ID: 38689295)
1. High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia.
Valery PC; Roche S; Brown C; O'Beirne J; Hartel G; Leggett B; Skoien R; Powell EE
Int J Equity Health; 2024 Apr; 23(1):84. PubMed ID: 38689295
[TBL] [Abstract][Full Text] [Related]
2. Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians.
Valery PC; Clark PJ; Pratt G; Bernardes CM; Hartel G; Toombs M; Irvine KM; Powell EE
Int J Equity Health; 2020 Feb; 19(1):27. PubMed ID: 32066438
[TBL] [Abstract][Full Text] [Related]
3. Patterns of primary health care service use of Indigenous Australians diagnosed with cancer.
Valery PC; Bernardes CM; de Witt A; Martin J; Walpole E; Garvey G; Williamson D; Meiklejohn J; Hartel G; Ratnasekera IU; Bailie R
Support Care Cancer; 2020 Jan; 28(1):317-327. PubMed ID: 31049670
[TBL] [Abstract][Full Text] [Related]
4. Opportunities for the management of metabolic dysfunction-associated fatty liver disease within Aboriginal and Torres Strait Islander peoples.
Dick S; Wheeler K; Keating SE
Aust N Z J Public Health; 2024 Apr; 48(2):100138. PubMed ID: 38442569
[No Abstract] [Full Text] [Related]
5. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
Younossi ZM; Paik JM; Stepanova M; Ong J; Alqahtani S; Henry L
J Hepatol; 2024 May; 80(5):694-701. PubMed ID: 38286339
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up.
Clark PJ; Valery PC; Ward J; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK
BMC Gastroenterol; 2022 Jul; 22(1):339. PubMed ID: 35820850
[TBL] [Abstract][Full Text] [Related]
7. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
Israelsen M; Torp N; Johansen S; Hansen CD; Hansen ED; Thorhauge K; Hansen JK; Villesen I; Bech K; Wernberg C; Andersen P; Lindvig KP; Tsochatzis EA; Thiele M; Rinella ME; Krag A;
Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):218-228. PubMed ID: 38218202
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study.
Wong CX; Brooks AG; Cheng YH; Lau DH; Rangnekar G; Roberts-Thomson KC; Kalman JM; Brown A; Sanders P
BMJ Open; 2014 Oct; 4(10):e006242. PubMed ID: 25344486
[TBL] [Abstract][Full Text] [Related]
9. Defining the gap: a systematic review of the difference in rates of diabetes-related foot complications in Aboriginal and Torres Strait Islander Australians and non-Indigenous Australians.
West M; Chuter V; Munteanu S; Hawke F
J Foot Ankle Res; 2017; 10():48. PubMed ID: 29151893
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer among Indigenous and non-Indigenous people in Queensland, Australia: Toward survival equality.
Moore SP; Green AC; Bray F; Coory M; Garvey G; Sabesan S; Valery PC
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e209-14. PubMed ID: 24571285
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia.
Wigg AJ; Narayana SK; Hartel G; Medlin L; Pratt G; Powell EE; Clark P; Davies J; Campbell K; Toombs M; Larkin M; Valery PC
EClinicalMedicine; 2021 Jun; 36():100919. PubMed ID: 34142069
[TBL] [Abstract][Full Text] [Related]
12. Overview of dialysis in indigenous compared to nonindigenous Australians.
Khanal N; Clayton P; McDonald S; Jose M
Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):123-127. PubMed ID: 27469158
[TBL] [Abstract][Full Text] [Related]
13. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey.
Enriquez R; Homsi M; Ssekubugu R; Nabukalu D; Zeebari Z; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekström AM; Hagström H; Nordenstedt H
Aliment Pharmacol Ther; 2024 May; 59(9):1111-1121. PubMed ID: 38459720
[TBL] [Abstract][Full Text] [Related]
15. The high burden of comorbidities in Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B in Far North Queensland, Australia, and the implications for patient management.
Riddell J; Hempenstall A; Nakata Y; Gregson S; Hayes R; Smith S; Coates M; Charlie L; Perrett C; Newie V; Newie T; Radlof S; Hanson J
PLoS One; 2023; 18(4):e0284151. PubMed ID: 37023060
[TBL] [Abstract][Full Text] [Related]
16. Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantage.
Clayton-Chubb D; Kemp WW; Majeed A; Lubel JS; Woods RL; Tran C; Ryan J; Hodge A; Schneider HG; McNeil JJ; Roberts SK
Liver Int; 2024 Jan; 44(1):39-51. PubMed ID: 37698034
[TBL] [Abstract][Full Text] [Related]
17. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
[TBL] [Abstract][Full Text] [Related]
18. Cancer survival differentials for Aboriginal and Torres Strait Islander peoples in Queensland: the impact of remoteness.
Cramb SM; Whop LJ; Garvey G; Baade PD
Cancer Causes Control; 2023 Jan; 34(1):13-22. PubMed ID: 36266522
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.
Perumpail BJ; Manikat R; Wijarnpreecha K; Cholankeril G; Ahmed A; Kim D
J Pediatr Gastroenterol Nutr; 2024 Apr; ():. PubMed ID: 38623942
[TBL] [Abstract][Full Text] [Related]
20. Drivers of access to cardiovascular health care for rural Indigenous Peoples: a scoping review.
Tane T; Selak V; Eggleton K; Harwood M
Rural Remote Health; 2024 May; 24(2):8674. PubMed ID: 38697785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
